These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25134468)

  • 21. In vitro cardiotoxicity assessment of environmental chemicals using an organotypic human induced pluripotent stem cell-derived model.
    Sirenko O; Grimm FA; Ryan KR; Iwata Y; Chiu WA; Parham F; Wignall JA; Anson B; Cromwell EF; Behl M; Rusyn I; Tice RR
    Toxicol Appl Pharmacol; 2017 May; 322():60-74. PubMed ID: 28259702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes.
    Matsui T; Miyamoto K; Yamanaka K; Okai Y; Kaushik EP; Harada K; Wagoner M; Shinozawa T
    Toxicol Appl Pharmacol; 2019 Nov; 383():114761. PubMed ID: 31533062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A non-invasive platform for functional characterization of stem-cell-derived cardiomyocytes with applications in cardiotoxicity testing.
    Maddah M; Heidmann JD; Mandegar MA; Walker CD; Bolouki S; Conklin BR; Loewke KE
    Stem Cell Reports; 2015 Apr; 4(4):621-31. PubMed ID: 25801505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Manipulation-free cultures of human iPSC-derived cardiomyocytes offer a novel screening method for cardiotoxicity.
    Rajasingh S; Isai DG; Samanta S; Zhou ZG; Dawn B; Kinsey WH; Czirok A; Rajasingh J
    Acta Pharmacol Sin; 2018 Oct; 39(10):1590-1603. PubMed ID: 29620051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automated patch clamp on mESC-derived cardiomyocytes for cardiotoxicity prediction.
    Stoelzle S; Haythornthwaite A; Kettenhofen R; Kolossov E; Bohlen H; George M; Brüggemann A; Fertig N
    J Biomol Screen; 2011 Sep; 16(8):910-6. PubMed ID: 21775699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of dual-cardiotoxicity evaluation method based on analysis of field potential and contractile force of human iPSC-derived cardiomyocytes / multielectrode assay platform.
    Lee SG; Kim J; Oh MS; Ryu B; Kang KR; Baek J; Lee JM; Choi SO; Kim CY; Chung HM
    Biochem Biophys Res Commun; 2021 May; 555():67-73. PubMed ID: 33813278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes.
    Guo L; Abrams RM; Babiarz JE; Cohen JD; Kameoka S; Sanders MJ; Chiao E; Kolaja KL
    Toxicol Sci; 2011 Sep; 123(1):281-9. PubMed ID: 21693436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Embryonic stem cells in predictive cardiotoxicity: laser capture microscopy enables assay development.
    Chaudhary KW; Barrezueta NX; Bauchmann MB; Milici AJ; Beckius G; Stedman DB; Hambor JE; Blake WL; McNeish JD; Bahinski A; Cezar GG
    Toxicol Sci; 2006 Mar; 90(1):149-58. PubMed ID: 16357009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model.
    Guo L; Coyle L; Abrams RM; Kemper R; Chiao ET; Kolaja KL
    Toxicol Sci; 2013 Dec; 136(2):581-94. PubMed ID: 24052561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of doxorubicin toxicity on cardiomyocytes using a dual functional extracellular biochip.
    Xiao L; Hu Z; Zhang W; Wu C; Yu H; Wang P
    Biosens Bioelectron; 2010 Dec; 26(4):1493-9. PubMed ID: 20732805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiparameter in vitro assessment of compound effects on cardiomyocyte physiology using iPSC cells.
    Sirenko O; Crittenden C; Callamaras N; Hesley J; Chen YW; Funes C; Rusyn I; Anson B; Cromwell EF
    J Biomol Screen; 2013 Jan; 18(1):39-53. PubMed ID: 22972846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiotoxicity screening: a review of rapid-throughput in vitro approaches.
    Li X; Zhang R; Zhao B; Lossin C; Cao Z
    Arch Toxicol; 2016 Aug; 90(8):1803-16. PubMed ID: 26676948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Characterization of Human Stem Cell-Derived Cardiomyocytes.
    Kirsch GE; Obejero-Paz CA; Bruening-Wright A
    Curr Protoc Pharmacol; 2014; 64():11.12.1-26. PubMed ID: 25152802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multielectrode Array (MEA) Assay for Profiling Electrophysiological Drug Effects in Human Stem Cell-Derived Cardiomyocytes.
    Clements M
    Curr Protoc Toxicol; 2016 May; 68():22.4.1-22.4.32. PubMed ID: 27145112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Trial in a Dish: Using Patient-Derived Induced Pluripotent Stem Cells to Identify Risks of Drug-Induced Cardiotoxicity.
    Lam CK; Wu JC
    Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):1019-1031. PubMed ID: 33472401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes.
    Grimm FA; Iwata Y; Sirenko O; Bittner M; Rusyn I
    Assay Drug Dev Technol; 2015 Nov; 13(9):529-46. PubMed ID: 26539751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms.
    Pang L; Sager P; Yang X; Shi H; Sannajust F; Brock M; Wu JC; Abi-Gerges N; Lyn-Cook B; Berridge BR; Stockbridge N
    Circ Res; 2019 Oct; 125(9):855-867. PubMed ID: 31600125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of cardiomyocyte contraction in human-induced pluripotent stem cell-derived cardiomyocytes.
    Pointon A; Harmer AR; Dale IL; Abi-Gerges N; Bowes J; Pollard C; Garside H
    Toxicol Sci; 2015 Apr; 144(2):227-37. PubMed ID: 25538221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells.
    Yokoo N; Baba S; Kaichi S; Niwa A; Mima T; Doi H; Yamanaka S; Nakahata T; Heike T
    Biochem Biophys Res Commun; 2009 Sep; 387(3):482-8. PubMed ID: 19615974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro detection of cardiotoxins or neurotoxins affecting ion channels or pumps using beating cardiomyocytes as alternative for animal testing.
    Nicolas J; Hendriksen PJ; de Haan LH; Koning R; Rietjens IM; Bovee TF
    Toxicol In Vitro; 2015 Mar; 29(2):281-8. PubMed ID: 25479353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.